Letrozole Tablet, Film Coated
Product Images NDC 71335-2396

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 71335-2396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)
FDA Label Image

Avet.jpg (Avet)

Avet.jpg (Avet)
FDA Label Image

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)
This text seems to provide statistical data comparing two treatments, Letrozole and Tamoxifen, based on the number of patients, events, and outcomes seen. The data includes the number of patients, events, percentages, and various metrics for each treatment group. The table shows a comparison of Letrozole and Tamoxifen in terms of their effectiveness and impact on patients.*
FDA Label Image

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)
FDA Label Image

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)
FDA Label Image

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)
FDA Label Image

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)
FDA Label Image

Figure 6

Figure 6
FDA Label Image

Label (Lbl713352396)

Label (Lbl713352396)
Each film-coated tablet contains Letrozole 2.5 mg. Letrozole tablets should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Keep this medication out of the reach of children. It must be dispensed in tight containers. Repackaged by Bryant Ranch Prepack, Inc. and manufactured by Beijing Yiling Bio-engineering Technology Co., Ltd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.